Maqola

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Nico van ZandwijkAsbestos Diseases Research Institute, Sydney, NSW, AustraliaNick PavlakisNorthern Cancer Institute, Sydney, NSW, AustraliaSteven KaoAsbestos Diseases Research Institute, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, AustraliaAnthony LintonDepartment of Oncology, Concord Repatriation General Hospital, Sydney, NSW, AustraliaMichael BoyerSydney Medical School, University of Sydney, Sydney, NSW, AustraliaStephen ClarkeNorthern Cancer Institute, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, AustraliaY. Wendy HuynhAsbestos Diseases Research Institute, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, AustraliaAgata ChrzanowskaSydney Medical School, University of Sydney, Sydney, NSW, AustraliaMichael FulhamDepartment of Molecular Imaging (PET and Nuclear Medicine), Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, AustraliaDale L. BaileyDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, NSW, AustraliaWendy A. CooperSydney Medical School, University of Sydney, Sydney, NSW, AustraliaLeonard KritharidesDepartment of Cardiology, Concord Repatriation General Hospital, Sydney, NSW, AustraliaLloyd J RidleyDepartment of Radiology, Concord Repatriation General Hospital, Sydney, NSW, AustraliaScott PattisonEnGeneIC, Sydney, NSW, AustraliaJennifer A. MacDiarmidEnGeneIC, Sydney, NSW, AustraliaHimanshu BrahmbhattEnGeneIC, Sydney, NSW, AustraliaGlen ReidSydney Medical School, University of Sydney, Sydney, NSW, Australia

2017en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

DOI: 10.1016/s1470-2045(17)30621-6

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba